Inhibrx Biosciences Inc.
Status: Publicly traded
Direct answer
Inhibrx Biosciences Inc. is publicly traded on NASDAQ under the ticker INBX.
Inhibrx Biosciences, Inc. is a clinical-stage biopharmaceutical company, which includes a pipeline of novel biologic therapeutic candidates, developed using proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize multivalent formats where the precise valency can be optimized in a target-centric way to mediate what is...
Can you invest in Inhibrx Biosciences Inc.?
Yes. Inhibrx Biosciences Inc. trades publicly on NASDAQ as INBX.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Inhibrx Biosciences Inc.
Detailed equity research is provided by MarketSnap.